Bioventus (BVS) Treasury Shares (2021 - 2026)
Bioventus filings provide 5 years of Treasury Shares readings, the most recent being $2.8 million for Q4 2025.
- On a quarterly basis, Treasury Shares changed N/A to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a N/A change, with the full-year FY2025 number at $2.8 million, changed N/A from a year prior.
- Treasury Shares hit $2.8 million in Q4 2025 for Bioventus, up from $159000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $3.9 million in Q1 2024 to a low of $159000.0 in Q3 2025.
- Median Treasury Shares over the past 5 years was $1.3 million (2022), compared with a mean of $1.7 million.
- Biggest five-year swings in Treasury Shares: surged 593.69% in 2022 and later tumbled 94.32% in 2025.
- Bioventus' Treasury Shares stood at $1.0 million in 2021, then grew by 16.11% to $1.2 million in 2022, then surged by 73.76% to $2.1 million in 2023, then surged by 35.53% to $2.8 million in 2024, then decreased by 0.82% to $2.8 million in 2025.
- The last three reported values for Treasury Shares were $2.8 million (Q4 2025), $159000.0 (Q3 2025), and $2.9 million (Q2 2025) per Business Quant data.